Anticancer derivative of butyric acid (Pivalyloxymethyl butyrate) specifically potentiates the cytotoxicity of doxorubicin and daunorubicin through the suppression of microsomal glycosidic activity.

Source:http://linkedlifedata.com/resource/pubmed/id/10860924

Download in:

View as

General Info

PMID
10860924